Small cell lung cancer poses a significant challenge across the world, particularly in low-middle-income countries where it is often associated with poor outcomes.
Lung Cancer Foundation of America
Non-profit Organizations
LCFA’s mission is the improvement in survivorship of lung cancer patients through the funding of transformative science.
About us
Lung Cancer Foundation of America (LCFA) focuses on: 1. Funding Research... specifically young investigators 2. Increasing Awareness for the leading cause of cancer death... Lung Cancer 3. Patient Education... Life should take your breath away, not lung cancer LCFA’s mission is the improvement in survivorship of lung cancer patients through the funding of transformative science. While raising funds to support lung cancer research, LCFA will raise the public’s awareness and serve as a resource for patients or anyone seeking answers, hope, and access to updated treatment information, scientific investigation, and clinical trials.
- Website
-
http://www.LCFAmerica.org
External link for Lung Cancer Foundation of America
- Industry
- Non-profit Organizations
- Company size
- 2-10 employees
- Headquarters
- Marina del Rey
- Type
- Nonprofit
- Founded
- 2007
- Specialties
- lung cancer research, Advocacy, Fundraising, Awareness, Grant Making, Patient Advocacy, Patient Education, Marketing, and Patient Speakers Bureau
Locations
-
Primary
Get directions
Marina del Rey, US
-
Get directions
15 S Franklin St
New Ulm, Minnesota 56073, US
Employees at Lung Cancer Foundation of America
-
Jim Baranski
Executive Director at Lung Cancer Foundation of America
-
Julie K. Levinson
Writer/Story Teller/Maker of Emotional Connections
-
Marnie Clark
Writer * Storyteller * Community Builder *Lung Cancer Advocate
-
Shannon Quirk
Professional Ballet Dancer & Administrative Aide at Lung Cancer Foundation of America
Updates
-
A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new findings from the University of Missouri School of Medicine.
Diabetes Drug Reduces Drug Resistance in Lung Cancer
medicine.missouri.edu
-
Non-small cell lung cancer accounts for around 85% of lung cancer cases worldwide. Promising clinical research is developing new treatments that hope to improve the lives of millions of patients.
Non-small cell lung cancer: the global clinical trials landscape 2024
clinicaltrialsarena.com
-
Scientists overcame cancer drug resistance in a new proof-of-concept study.
'I've never seen anything like this': Scientists hijack cancer genes to turn tumors against themselves
livescience.com
-
Scientists have identified over 5,000 genetic variants that help certain cancers thrive, as well as a potential therapeutic target that could treat or possibly prevent these cancers from developing.
Scientists Have Identified Over 5000 High-Risk Cancer Gene Variants
https://scitechdaily.com
-
Detecting lung cancer as early as possible has long been a goal of the specialists at MSK, because it gives doctors the most treatment options, which can improve outcomes for patients.
A Promising New Test for Lung Cancer: The Noninvasive E-Nose
mskcc.org
-
Patients with stage 4 lung cancer show high response rates after an anti-inflammatory drug is added temporarily to immune checkpoint inhibitor therapy.
Slowing inflammation may boost immunotherapy’s effectiveness against advanced lung cancer | Penn Today
penntoday.upenn.edu
-
AI-powered solutions for opportunistic lung cancer detection using routine chest X-rays offer hope for improved early diagnosis and survival rates.
The Role of AI in Empowering Early Lung Cancer Detection & Transforming Patient Outcomes - MedCity News
https://medcitynews.com
-
Study links neighborhood violence, lung cancer progression
Study links neighborhood violence, lung cancer progression
medicalxpress.com
-
Air Pollution Makes Cancer Patients More Vulnerable To Cardiovascular Disease
Air Pollution Makes Cancer Patients More Vulnerable To Cardiovascular Disease
social-www.forbes.com